We are excited to welcome thirty medical trainees to Orlando, Florida, for the HTRS Trainee Workshop: Winter 2025. This year’s cohort will have the opportunity to learn from our distinguished faculty through an engaging and immersive program.

🌍 Reminder: ASH International Outreach Initiative Applications Now Open! The ASH IOI aims to bridge the gap in #hematology education by offering free educational resources to institutions in low- and middle-income countries. 🔗 https://bit.ly/4liN3yc#hematology #HemeSky #MedSky

PCP has pt on 4 agents for sleep/RLS…has never checked iron…ferritin of 6…what are we doing chat

🚨Abstract submissions for EAHAD 2026 are now open! Share your research with leading experts in haemophilia and bleeding disorders before 27 October ➡️

Pass the hematology boards with flying colors! 💫 Join the ASH Hematology Review Series for expert lectures and live sessions until October 6. Enroll today: https://bit.ly/3RR5bCN #ABIM #HemeSky #MedSky #BoardExamsPrep

Heme fellows apply! Networking and career mentorship ! #hemesky #meded

Good news! The Senate’s leadership is proposing a $400M NIH funding increase for FY26. Now ASH urges the House to support the Senate numbers. ASH can’t do it alone—join the #Fight4Hematology: call, email, or meet with your Rep today. 🔗 https://bit.ly/3YeapvY

Interested in a mentor to guide your career in malignant hematology? Apply for the ASH’s new Mentorship Program, and grow your network! Deadline: Sept 26. Apply today! 🔗 https://bit.ly/3IPWjMA Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t #HemeSky

So impressed at the increased support the American Society of Hematology is planning for trainees and early-career investigators!! At some point, someone invested in us. Now it’s our turn. #Fight4Hematology and secure the future of hematology research. Donate! #hemesky www.hematology.org/foundation

💡An exciting illustrated review of "Gene-based therapies for hemophilia," by Wolfgang Miesbach et al is now available as full-OA article in @isth.org @rpth.bsky.social! It provides a compreh. overview of #genetherapy for #hemophilia A & B, highlighting recent advances in patient care. bit.ly/40RHmQ8

Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis. Learn more in this Review. https://ja.ma/4krNDZU

Meta-analysis on GLP-1RA (vs. placebo) and VTE: 🔹 PE rates significantly lower 📉 🔹 VTE rates lower but not statistically significant 🔹 No difference in DVT 🔹 Study design matters: RCTs vs. observational data Accepted for publication in JTH! #ISTH2025 #VTE #GLP1RA #Thrombosis @jthjournal.bsky.social

This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%! Practice changing investigator-initiated RCT. #ISTH2025

Day 3 of #ISTH2025 with the Hopkins Complement Crew #hemesky

Why is managing hypertensive disorders during pregnancy challenging? Tune in with Drs. Richard Burwick and Shruti Chaturvedi for a new HemeTalks episode for insights on pre-eclampsia, diagnostic tests, and management strategies! 🎧 https://bit.ly/3XwnXCD #HemeSky @ash.edu.hematology.org‬

Updated Guidelines in TTP treatment just dropped at #ISTH2025 pubmed.ncbi.nlm.nih.gov/40533296/

Why do some people with the Duffy null phenotype have an ANC below most institutional reference ranges? Explore the mechanism behind this phenomenon 👇 Learn more: www.hematology.org/e... #DuffyNull #HemeSky #MedSky #DANC #ASHEducation @ash.edu.hematology.org

Platelet refractoriness describes a poor response to platelet transfusion, and conventional thinking has divided etiologies into 2 broad categories: immune and nonimmune. buff.ly/JEfMzzB #hemesky #transfusionmedicine #HowITreat

#ASHSlideSaturday 🩸: Examine the slide from the #ASHImageBank. Identify the cells and where you may see them. Tune in tomorrow for the answer! #ASHEducation #Microlearning #MedEd #Hemesky #Hematology #Hematologist #MedicalEducation #TIL

Super amazing opportunity for students and trainees interested in hematology! #MedSky

The entire CDC lead program has been eliminated. Lead exposure can lead to many issues including anemia & irreversible brain damage in young children. It was <10 years ago we learned that 99,000 people in Flint Michigan had been exposed. If only eliminating programs eliminated the risk.

Mild neutropenia may not need a bone marrow biopsy…. DANC can be diagnosed with just a quick easy blood test!

Now the D-team has chainsawed the CDC Division of Blood Diseases... Thanks @ash.hematology.org 90+ other organizations for speaking up! This action has immediate harms to the health of Americans. www.medpagetoday.com/hematologyon...

Super exciting results regarding extended dose reduction of Apixaban in cancer- associated VTE #hemesky www.nejm.org/doi/full/10....

If you are a healthcare provider and EVER draw labs to evaluate for iron deficiency you should know -ferritin is best unless ongoing inflammation -serum iron is USELESS -a single digit ferritin result is NEVER NORMAL even if your lab says it is #MedSky

Have you put in your application for the ASH Trainee Council? Open for just 6 more days! Med students, international trainees, PhD students and post docs, residents, fellows - you are eligible! www.hematology.org/education/tr...

❓Are you ready for #Hemophilia rebalancing therapies? 💡Join the @isth.org webinar on how to assess emerging rebalancing therapies & prepare treatment teams for their use 🎙️Speakers: Speaker(s): Amy Shapiro, Stacy Croteau 🗓️Feb. 26, 2025 15:00 PM UTC 👉https://buff.ly/3E77Apo

Just your regular reminder that iron deficiency affects ~40% of 12-21 yo females and still no one cares. jamanetwork.com/journals/jam...

The fabulous Dr. Tola Fatola presenting her ASH HIP Award project at #ASH24. What a phenomenal presentation!! True heme superstar! 🩸⭐️🩸 #ProudMentor #SickleCell @ash-hematology.bsky.social @oslerresidency.bsky.social

Health insurance is wild. You pay every month for months, years, decades, in case something catastrophic happens. Then it does and the insurers are like yeah no not THAT kind of catastrophe.

8 days ago, ASH decided to join Bluesky. 🌤️ So far, we're enjoying fewer distractions & more meaningful connections. 💬 Engaging with our amazing #hematology and #hemeonc communities has never been easier. We created an #ASH24 feed for you & we have more feeds coming soon: bit.ly/ASH24feed #Hemesky

Get ready to submit your research to the ISTH 2025 Congress in DC! Abstract submission site opens this Friday, November 29th. Submit your work for presentation to an intl audience & connect w/ others from around the 🌎: www.isth2025.org/abstracts 🩸 #hemesky #hemostasis #thrombosis

If we ignore Duffy-null associated neutrophil counts (DANC), we contribute to major disparities in oncology care and clinical trial enrollment. Whether you’re a clinical trialist or clinician, a must-read from @laurenmerzmd.bsky.social and coauthors #medsky #hemesky 🩸🧪 www.nejm.org/doi/abs/10.1...

Acquired hemophilia is a severe bleeding disorder that is difficult to treat. This review provides an algorithmic approach to treatment that includes emicizumab, limits hemostatic product use, and minimizes immunosuppression toxicity. www.jthjournal.org/article/S153... #MedSky #HemeSky

So much FOMO. Will watch from home 😭🩸🧬🧪 #ASH2024

Ongoing live FDA discussion regarding Andexxa clinical benefit in light of increased thrombotic events... #Medsky #hemesky www.youtube.com/live/xztpe5-...

Top three hematology pearls for pediatricians #medsky #hemesky 1. Serum iron level is useless 2. Thrombocytosis is reactive 99% of the time 3. Percentage values on WBC differential don’t matter, only absolute values

Are HIT immunoassays truly "positive" or "negative"? 🩸 Not so simple! Using data from 1,393 patients, this study reveals diagnostic value across the entire dynamic range of H/PF4 assays 📊 #HIT #platelet #MedSky #HemeSky #CardioSky www.jthjournal.org/article/S153...

Polycythemia vera is a clonal myeloproliferative neoplasm that causes erythrocytosis and is typically associated with a JAK2 gene variant. This narrative review investigates the diagnosis, symptoms, and management of polycythemia vera. https://ja.ma/3UUmfcY

Rank Lists for #HemeFellowshipMatch2025 are due November 20th!! Our ASH HFFTP institutions are excited to match the next cohort of #ClassicalHeme superstars!! 🩸⭐🩸 www.hematology.org/education/ed...